ClinicalTrials.govpublic full text
Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma
relapsed and refractory multiple myeloma, multiple myeloma,, relapsed and refractory,, lgh447,, pan-pim inhibitor,, pim kinase,, byl719,, pi3k inhibitor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 851980
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.